TAG ARCHIVES FOR research ethics roundup

19
May2017

This week’s Research Ethics Roundup highlights a Nature editorial that encourages researchers to push back against both public and private forms of censorship in research contracts, the National Institute of Health (NIH)’s Comparative Genomics Branch issues new study with implications for both human and dog disease research, the World Health Organization (WHO) speaks with Doctors Without Borders about using an experimental vaccine to target a new Ebola outbreak, and bioethicists' concern about stem cell researchers' failure to publish study results including discoveries on side effects. Read more

5
May2017

This week’s Research Ethics Roundup reviews the ways research with biospecimens has changed since Henrietta Lacks' story made news, how the National Institutes of Health (NIH)'s grant application changes focus on transparency in preclinical research, how ethicists can avoid stereotyping prisoners who choose to participate in research, and how one of the top research search engines is improving transparency efforts. Read more

21
Apr2017

This week’s Research Ethics Roundup examines the New England Journal of Medicine’s (NEJM) editor-in-chief’s call for a new approach to sharing clinical trial data, how experts are trying to improve drug testing success rates by reviewing pre-clinical research assumptions, a National Academies committee’s call for a nongovernmental body to promote research integrity, and a new study that rebuts critics’ claims that the Food and Drug Administration (FDA) is slow to approve new drugs for the American market. Read more

7
Apr2017

This week’s Research Ethics Roundup reviews how experts think data sharing can be accelerated with data authorship attribution, how southern Africa’s San people are combatting exploitative research, the President’s plan for National Institutes of Health (NIH) grants, and a better way to transport laboratory mice. Read more

27
Mar2017

This week’s Research Ethics Roundup examines why legal experts are advising against voluntary compliance of Common Rule changes, President Trump’s plan for the National Institutes of Health (NIH)’s budget, the debate over whether technology can replace animal models in research, and the reaction to President Trump’s pick for Food and Drug Administration (FDA) Commissioner. Read more

Page 2 of 1912345...10...Last »